Amendment of Statement of Principles concerning chronic blepharitis No. 21 of 2004

Overview

The legislative instrument, numbered 21 of 2004, amends the Statement of Principles concerning chronic blepharitis under the Veterans' Entitlements Act 1986. This amendment, introduced by the Repatriation Medical Authority, responds to the need for an updated definition of "irritant substances" as it pertains to chronic blepharitis. The previous definition was deleted and replaced to better encapsulate substances causing an irritant effect, including dyes, oils, industrial chemicals, tobacco smoke, or CS agent. The purpose of this amendment is to ensure the definition aligns with current understandings of what constitutes an irritant substance, thereby facilitating more accurate assessments and entitlements for affected veterans. This legislative amendment applies to all matters governed by Instrument No. 117 of 1995 and section 120A of the Veterans' Entitlements Act 1986. The intent behind the change is to refine the criteria for identifying and addressing irritant substances that could contribute to chronic blepharitis, ensuring that the medical authority's guidelines are both comprehensive and contemporary. The Repatriation Medical Authority, acting under subsection 196B(2) of the Act, has made this amendment to enhance the efficacy and fairness of the entitlements process for veterans.

Scope and Application

The legislative instrument amends the Statement of Principles concerning chronic blepharitis for the purposes of the Veterans’ Entitlements Act 1986, specifically altering the definition of "irritant substances" within the context of veterans' claims related to this condition. The amendment narrows the scope of irritant substances to those explicitly listed, such as dyes, oils, industrial chemicals, tobacco smoke, or CS agent, thereby removing the previous broad definition. This change applies to all matters governed by Instrument No. 117 of 1995 and section 120A of the Act, ensuring that any claims or assessments concerning chronic blepharitis under these provisions are assessed with the updated definition in mind. The amendment reflects a more precise approach to identifying substances that may cause an irritant effect, potentially impacting the eligibility and assessment of veterans' claims for chronic blepharitis.

Key Provisions

The key provision of this legislative instrument (Instrument No. 21 of 2004) is the amendment of the definition of "irritant substances" under clause 4 of Instrument No. 117 of 1995, as amended by the Veterans’ Entitlements Act 1986 (the Act) (subsection 196B(2)). The amendment clarifies that "irritant substances" now refers to substances that cause an irritant effect, specifically naming dyes, oils, industrial chemicals, tobacco smoke, and CS agent (section 1). This amendment ensures that the definition is more precise and comprehensive, covering a wider range of substances that can cause irritation. Under this legislation, the Repatriation Medical Authority has imposed obligations on the entities it governs. Specifically, this amendment requires a revised understanding and application of the term "irritant substances" when assessing claims related to chronic blepharitis under the Act. This means that any claims involving exposure to the newly defined irritant substances must be evaluated in light of this updated definition (section 1). The amendment applies to all matters to which Instrument No. 117 of 1995, and section 120A of the Act apply, ensuring consistency across relevant cases (section 2). In terms of breaches and consequences, the Act does not explicitly state any offences, penalties, or specific civil or criminal consequences for non-compliance with the amended definition of "irritant substances." However, the authority responsible for administering the Act may take action against any entity or individual found to be in breach of the amended provisions. Such action could include the denial or revocation of entitlements, reassessment of claims, or other administrative penalties deemed appropriate by the Repatriation Medical Authority. While the Act itself does not outline specific penalties, the consequences of non-compliance could potentially lead to significant legal and financial repercussions for those involved.